4//SEC Filing
MORVILLE MALCOLM 4
Accession 0001181431-05-007236
CIK 0000854222other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 3:22 PM ET
Size
10.8 KB
Accession
0001181431-05-007236
Insider Transaction Report
Form 4
MORVILLE MALCOLM
Director
Transactions
- Exercise of In-Money
Common Stock, par value $.001 per share
2005-02-02$2.38/sh+6,500$15,438→ 20,750 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-02-02$2.38/sh−6,500$15,438→ 0 totalExercise: $2.38From: 2002-04-05Exp: 2010-04-05→ Common Stock, par value $.001 per share (6,500 underlying) - Exercise of In-Money
Common Stock, par value $.001 per share
2005-02-02$2.36/sh+1,250$2,950→ 14,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-02-02$2.36/sh−1,250$2,950→ 3,750 totalExercise: $2.36From: 2004-03-12Exp: 2013-03-12→ Common Stock, par value $.001 per share (1,250 underlying)
Footnotes (2)
- [F1]Represents exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
- [F2]Represents shares acquired through exercise of stock options granted pursuant to the Company's 2000 Stock Option Plan.
Documents
Issuer
INDEVUS PHARMACEUTICALS INC
CIK 0000854222
Entity typeother
Related Parties
1- filerCIK 0001244152
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 3:22 PM ET
- Size
- 10.8 KB